Healthineers Trims Buyback Tally as Breakup Costs and a New Name Take Shape
Published on 11/15/2026 at 15:41 | Editorial boerse-global.de
Siemens Healthineers picked up another 50,000 of its own shares in the week running from 2 to 8 November, the company said on 9 November. That brings the total repurchased since the programme opened on 1 June to roughly 3.68 million shares.
The buyback is running alongside a far larger restructuring story. On 5 November the group confirmed that it intends to trade simply as "Healthineers" once it is spun off from Siemens, subject to shareholder approval at the annual general meeting in February 2027. The brand switch is scheduled to start in 2027 and roll out over three years, giving the standalone company a fresh corporate identity.
Diagnostics to become Olyrian
At the heart of the separation is the carve-out of the in-vitro diagnostics unit, which will be built up step by step under the name Olyrian Diagnostics. Management expects to complete the separation by mid-2028.
Should investors sell immediately? Or is it worth buying Siemens Healthineers?
Getting there will not come cheap. Siemens Healthineers has announced a savings programme dubbed "Transform4 Future" for 2028, under which more than EUR 300 million in costs are to be offset across the group. Those costs stem from the planned diagnostics spin-off, the split from Siemens and the downsizing of the ultrasound business. Finance chief Jochen Schmitz added that a further EUR 400 million of savings is targeted within the diagnostics division being carved out.
Analysts weigh the quarter
Graham Doyle flagged expected charges from the diagnostics separation among the factors weighing on the stock. In his reading of the quarterly figures, group revenue growth came in slightly ahead of expectations, while adjusted EBIT fell short.
For fiscal 2026, Siemens Healthineers reported comparable revenue growth of 4.0%, an adjusted EBIT margin of 16.2% and adjusted undiluted earnings per share of EUR 2.42.
Ad
Siemens Healthineers Stock: New Analysis - 15 November
Fresh Siemens Healthineers information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
